User profiles for Angelo D’Alessandro

Angelo D'Alessandro

University of Colorado - Anschutz Medical Campus
Verified email at cuanschutz.edu
Cited by 23832

[HTML][HTML] COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status

…, KC Hansen, EA Hod, SL Spitalnik, A D'Alessandro - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Reprogramming of host metabolism supports viral pathogenesis by fueling
viral proliferation, by providing, for example, free amino acids and fatty acids as building …

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

…, A Winters, S Pei, M Minhajuddin, A D'Alessandro… - Nature medicine, 2018 - nature.com
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Leukemia stem
cells (LSCs) drive the initiation and perpetuation of AML, are quantifiably associated with …

[PDF][PDF] Inhibition of amino acid metabolism selectively targets human leukemia stem cells

CL Jones, BM Stevens, A D'Alessandro, JA Reisz… - Cancer cell, 2018 - cell.com
In this study we interrogated the metabolome of human acute myeloid leukemia (AML) stem
cells to elucidate properties relevant to therapeutic intervention. We demonstrate that amino …

[HTML][HTML] Red blood cell storage lesion: causes and potential clinical consequences

T Yoshida, M Prudent, A D'Alessandro - Blood Transfusion, 2019 - ncbi.nlm.nih.gov
Red blood cells (RBCs) are a specialised organ that enabled the evolution of multicellular
organisms by supplying a sufficient quantity of oxygen to cells that cannot obtain oxygen …

Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients

…, KC Hansen, SL Spitalnik, A D'Alessandro - Journal of proteome …, 2020 - ACS Publications
The SARS-CoV-2 beta coronavirus is the etiological driver of COVID-19 disease, which is
primarily characterized by shortness of breath, persistent dry cough, and fever. Because they …

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

…, T Nemkov, A D'Alessandro… - Proceedings of the …, 2018 - National Acad Sciences
Activation of the NLRP3 inflammasome induces maturation of IL-1β and IL-18, both validated
targets for treating acute and chronic inflammatory diseases. Here, we demonstrate that …

An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies

A D'Alessandro, AG Kriebardis, S Rinalducci… - …, 2015 - Wiley Online Library
Red blood cell ( RBC ) aging in the blood bank is characterized by the accumulation of a
significant number of biochemical and morphologic alterations. Recent mass spectrometry and …

[PDF][PDF] p53 represses the mevalonate pathway to mediate tumor suppression

…, E de Stanchina, L Zender, DR Tong, A D'Alessandro… - Cell, 2019 - cell.com
There are still gaps in our understanding of the complex processes by which p53 suppresses
tumorigenesis. Here we describe a novel role for p53 in suppressing the mevalonate …

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

…, A D'Alessandro, A Winters, A Krug, D Abbott… - Nature cancer, 2020 - nature.com
Venetoclax with azacitidine (ven/aza) has emerged as a promising treatment regimen for
acute myeloid leukemia (AML), with a high percentage of clinical remissions in newly …

Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia

…, JR Myers, JM Ashton, T Nemkov, A D'Alessandro… - Cancer discovery, 2020 - AACR
Identifying characteristics of patients who respond poorly to venetoclax-based therapy and
devising alternative therapeutic strategies for such patients are important topics in AML. We …